FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)

Lobbying for DRAGONFLY THERAPEUTICS, INC. · Clinical-stage biopharmaceutical company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Taxation/Internal Revenue Code

Lobbying related to deductibility of research and development expenses.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.